Furthermore, dysfunctional AMPK could have a key role in advanced NAFLD since it was recently shown that the kinase can phosphorylate the proapoptotic caspase 6 to inhibit its activation and to control for hepatocellular apoptosis in NASH [212]. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.